InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Priebe Waldemar, 管理人员. Director active across 1 company, notably CNS Pharmaceuticals, Inc.. In total, 2 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €13k. History available since 6 December 2022. The latest transaction was disclosed on 6 December 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Priebe Waldemar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
5,500 股@ US$2.47100.0% 占其流量Common StockSEC:0000897069-23-001044:0
1,495,867 股Common StockSEC:0001683168-22-000460:0
2 条申报中的 2 条
About Priebe Waldemar
Waldemar Priebe is an Executive at CNS Pharmaceuticals, Inc. He is involved in the company's operations, contributing to the implementation of strategy and management of activities. His role is essential for the smooth functioning of the company.
